Related references
Note: Only part of the references are listed.Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021
Olivia Bupha-Intr et al.
INTERNAL MEDICINE JOURNAL (2021)
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021
Benjamin W. Teh et al.
INTERNAL MEDICINE JOURNAL (2021)
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021
Abby P. Douglas et al.
INTERNAL MEDICINE JOURNAL (2021)
Infection-Related Mortality in Adults and Children Undergoing Allogeneic Hematopoietic Cell Transplantation: An Australian Registry Report
Julian Lindsay et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient
Dionysios Neofytos
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT
Beata Sienkiewicz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials
Cho-Hao Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Randy A. Taplitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Real-Life Challenges to the Use of Antifungal Agents in Hematology Patients
Anthony J. Perissinotti et al.
CURRENT FUNGAL INFECTION REPORTS (2017)
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis
Ying Jiao Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Andrew J. Ullmann et al.
ANNALS OF HEMATOLOGY (2016)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
Neil R. H. Stone et al.
DRUGS (2016)
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan
Ching-Hsun Wang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
Eric J. Bow et al.
BMC INFECTIOUS DISEASES (2015)
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients
Maria J. G. T. Vehreschild et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014
S. Fleming et al.
INTERNAL MEDICINE JOURNAL (2014)
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
Helen Y. Chu et al.
BMC INFECTIOUS DISEASES (2013)
Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies
Mary Mansour Riwes et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
G. P. Aithal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
Roger J. M. Bruggemann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hallucinations during voriconazole therapy
Dimitrios I. Zonios et al.
CLINICAL INFECTIOUS DISEASES (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Share Paper
